Is there a role of platelet-activating factor in human lung cancer?

Lung Cancer

Volumn 33, Issue 2-3, 2001, Pages 195-202

  Denizot, Y ^a   Desplat, V ^b   Drouet, M ^a   Bertin, F ^c   Melloni, B ^d  

^a CNRS   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c DUPUYTREN UNIVERSITY HOSPITAL   (France)

^d Hopital du Cluzeau   (France)

Author keywords

Acetylhydrolase activity; Lung cancer; Platelet activating factor; Receptor

Indexed keywords

1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; ACYLTRANSFERASE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ACETYLATION; ADULT; AGED; ANGIOGENESIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0034904022     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00197-0     Document Type: Article

References (25)

1. Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver
2. Platelet-activating factor: biosynthesis, biodegradation, actions
3. Expression of platelet-activating factor receptor transcript-1 but not transcript-2 by human bone marrow cells
4. Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line
5. Expression of vascular endothelium growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease
6. Prognostic significance of angiogenesis in human pancreatic cancer
7. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers
8. Effect of cigarette smoking on the levels of platelet-activating factor-like lipid(s) in plasma lipoproteins
9. Augmentation of tumor metastasis by platelet-activating factor
10. Platelet-activating factor receptor: gene expression and signal transduction
11. The role of platelet-activating factor and other lipid mediators in inflammatory angiogenesis
12. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival
13. Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A
14. Potential role of platelet-activating factor in human breast cancer
15. Elevated levels of paf-acether in blood of patients with type 1 diabetes mellitus
16. Regulation of platelet-activating factor receptor expression in human B cells and B cell lines
17. Elevated plasma levels of platelet-activating factor (PAF) in breast cancer patients with hypercalcemia
18. Mortality from smoking worldwide
19. Presence of PAF-acether in human breast carcinoma: relation to axillary lymph node metastasis
20. Agonist-induced up-regulation of platelet-activating factor receptor messenger RNA in human monocytes
21. VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor
22. Mammalian platelet-activating factor acetylhydrolases
23. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase
24. The local cell response to human lung carcinomas
25. Immunohistochemical study with monoclonal antibodies on immune response in human lung cancers